跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
PRO-DESVENLAFAXINE
Authorized
STANDARD
PRO-DESVENLAFAXINE
PRO DOC LIMITEE
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
0196dfd82ee9c2af
Company
PRO DOC LIMITEE
Type
Standard
Approval Details
Approval Id
0196dfd82ee9c2af
Drug Approval Canada Name
PRO-DESVENLAFAXINE
Product Name
PRO-DESVENLAFAXINE
Status
Cancelled Post Market
Status Date
2024-05-24
Original Market Date
2022-10-05
Din
02526913
Drug Class
Human
Dosage Form
Tablet (Extended-Release)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:16.04.16
Atc Original
N06AX23 DESVENLAFAXINE
Atc Name
n 06 ax 23
Aig Number
0152509001
Company Name
PRO DOC LIMITEE
Company Address
2925 Boulevard Industriel, Laval, Quebec, Canada, H7L 3W9
Active Ingredients
DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE)
50 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
0196dfd82ee9c2af
Type
Standard
Back to Health Canada Approvals
PRO-DESVENLAFAXINE - Health Canada Drug Approval Details